Literature DB >> 3314499

Significance of anticentromere antibody in idiopathic Raynaud's syndrome.

J Sarkozi1, A A Bookman, P Lee, E C Keystone, M J Fritzler.   

Abstract

Fifty-eight patients with Raynaud's syndrome who had no evidence of definite underlying connective tissue disease had serum analyzed for the presence of anticentromere antibody using indirect immunofluorescence techniques on HEp-2 cell lines. Eighteen patients (31 percent) were anticentromere antibody-positive. The anticentromere antibody-positive group demonstrated significantly more frequent digital telangiectases, digital edema, elevated levels of immunoglobulins, and low C4 values. Photoplethysmography revealed significantly diminished blood flow in the anticentromere antibody-positive group. Capillary microscopy revealed significantly increased avascularity and number of dilated loops in the anticentromere antibody-positive group. Giant loops were seen exclusively in the anticentromere antibody-positive group. The clinical findings in the anticentromere antibody-positive group are suggestive of a transition to a connective tissue disease with features of the CREST syndrome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3314499     DOI: 10.1016/0002-9343(87)90647-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

Review 1.  Anti-centromere antibodies (ACA).

Authors:  C G Kallenberg
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 2.  [Raynaud phenomenon in dermatology. Part 1: Pathophysiology and diagnostic approach].

Authors:  C Sunderkötter; G Riemekasten
Journal:  Hautarzt       Date:  2006-09       Impact factor: 0.751

Review 3.  How useful are serum autoantibodies in the diagnosis and prognosis of systemic sclerosis?

Authors:  O Meyer
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 4.  Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex.

Authors:  C G Kallenberg
Journal:  Clin Rev Allergy       Date:  1994

5.  Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon.

Authors:  Slavica Pavlov-Dolijanovic; Nemanja S Damjanov; Roksanda M Stojanovic; Nada Z Vujasinovic Stupar; Dejana M Stanisavljevic
Journal:  Rheumatol Int       Date:  2011-09-08       Impact factor: 2.631

6.  Clinical correlation of anticentromere antibodies.

Authors:  M Zuber; R Gotzen; I Filler
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

7.  Management of cutaneous vascular complications in systemic scleroderma: experience from the German network.

Authors:  Ilka Herrgott; Gabriela Riemekasten; Nicolas Hunzelmann; Cord Sunderkötter
Journal:  Rheumatol Int       Date:  2008-03-05       Impact factor: 2.631

Review 8.  The clinical relevance of autoantibodies in scleroderma.

Authors:  Khanh T Ho; John D Reveille
Journal:  Arthritis Res Ther       Date:  2003-02-12       Impact factor: 5.156

9.  Late-Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor-Induced Raynaud's-Like Phenomenon.

Authors:  Shaheen Khan; Mitchell S von Itzstein; Rong Lu; Bonnie L Bermas; David R Karp; Saad A Khan; Farjana J Fattah; Jason Y Park; Jessica M Saltarski; Yvonne Gloria-McCutchen; Yang Xie; Quan-Zhen Li; Edward K Wakeland; David E Gerber
Journal:  Oncologist       Date:  2020-03-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.